FDA approves Sanofi/Regeneron cholesterol drug with limits

July 24, 2015 6:23 PM

6 0

WASHINGTON, July 24 The U.S. Food and Drug Administration approved a potent new cholesterol-lowering drug from Sanofi SA and Regeneron Pharmaceuticals Inc on Friday but limited its approved use to patients with a hereditary form of the condition and those with cardiovascular disease.

The FDA ruling came just hours after European regulators recommended approval for broader use of the drug in all patients with high cholesterol who are not able to bring it down despite taking maximal doses of statin. The Europeans also recommended it for patients who cannot tolerate statins.

Also read: National Cancer Institute Says Researchers Didn’t Quickly Tell FDA After Two Deaths in a Lymphoma Study

Read more

To category page